Company Info
Material science |
Epoch Biodesign |
2021 – present |
2 Rounds Invested |
Epoch Biodesign is a SynBio company that is developing tools for adapting biology. Their first project has been to design enzymes that transform plastic waste into everyday chemicals. Plastic production is chocking our planet and spewing out carbon emissions and today there are no solutions available at any meaningful scale. Biorecycling offers a scalable solution to unlock the true value of plastic waste. The company has raised three rounds of financing to date, the most recent being an $11M round led by Lower Carbon Capital in 2022.